Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Kontron Aktie 10395864 / AT0000A0E9W5

29.10.2025 20:25:03

EQS-News: Kontron publishes preliminary figures for the first nine months of 2025 - Profit guidance for 2025 confirmed

EQS-News: Kontron AG / Key word(s): Preliminary Results
Kontron publishes preliminary figures for the first nine months of 2025 - Profit guidance for 2025 confirmed

29.10.2025 / 20:25 CET/CEST
The issuer is solely responsible for the content of this announcement.


Linz, October 29, 2025 - Kontron, a global leader in IoT technology, today announces preliminary financial results for the first nine months of 2025 in response to the recent, fundamentally unfounded decline in its share price and to prevent market speculation.

According to preliminary calculations, revenue in the first nine months of 2025 amounted to EUR 1,182 million compared to EUR 1,208 million in the same period of the previous year and takes the discontinuation of the COM business into account. According to preliminary data, EBITDA for the first nine months increased to EUR 194 million, which corresponds to an increase of 37% compared to the previous year's figure of EUR 141 million. This includes a one-off effect of around EUR 46 million from the deconsolidation of the COM business. On an operating basis, EBITDA in the first nine months of the current financial year amounted to around EUR 148 million.

Revenue for the full year 2025 is affected by the discontinuation of the COM business and the focus on business with higher margins and is currently expected to be EUR 1.7 billion (previously EUR 1.8 billion). Management expects EBITDA to remain unchanged at around EUR 270 million. This includes approximately EUR 220 million in operating EBITDA as well as preliminary one-off income of around EUR 46 million from the portfolio adjustment.

Hannes Niederhauser, CEO of Kontron AG, comments: "We continue to see strong order intake with a book-to-bill >1x; especially in the areas of railway infrastructure, defense, aerospace and artificial intelligence." 

Kontron will publish its full results for the first nine months of 2025 on November 5 as planned.

 

About Kontron

Kontron AG (www.kontron.com, ISIN AT0000A0E9W5, WKN A0X9EJ, KTN) is a leading IoT technology company. For more than 20 years, Kontron has been supporting companies from a wide range of industries to achieve their business goals with intelligent solutions. From automated industrial operations, smarter and safer transport to advanced communications, connectivity, medical, and energy solutions, the company delivers technologies that add value for its customers. With the acquisition of Katek SE in early 2024, Kontron significantly strengthens its portfolio with the new GreenTec division, focusing on solar energy and eMobility, and grows to around 7,000 employees in over 20 countries worldwide. Kontron is listed on the SDAX® and TecDAX® of the German Stock Exchange.

 

Follow Kontron:

 

Media Contacts

Alexandra Kentros
Kontron AG - Communications
Tel: +49 (0) 151 151 938 81
group-pr@kontron.com
Leon-Philipp Kleiss
Kontron AG – Investor Relations
Tel: +43 (0) 664 60191 5153
ir@kontron.com
 
 
 
 
 
 

All rights reserved. Kontron is a trademark or registered trademark of Kontron Europe GmbH. All other brand or product names are trademarks or registered trademarks or copyrights by their respective owners and are recognized. All data is for information purposes only and not guaranteed for legal purposes. Subject to change without notice. Information in this press release has been carefully checked and is believed to be accurate; however, no responsibility is assumed for inaccuracies.



29.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Kontron AG
Industriezeile 35
4020 Linz
Austria
Phone: +43 (732) 7664 - 0
E-mail: ir@kontron.com
Internet: https://www.kontron.com
ISIN: AT0000A0E9W5
WKN: A0X9EJ
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange; BX, Vienna Stock Exchange (Vienna MTF)
EQS News ID: 2220768

 
End of News EQS News Service

2220768  29.10.2025 CET/CEST

Analysen zu Kontron

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
06.08.25 Kontron Buy Warburg Research
06.08.25 Kontron Buy Jefferies & Company Inc.
02.07.25 Kontron Buy Warburg Research
19.06.25 Kontron Buy Warburg Research
26.05.25 Kontron Buy Jefferies & Company Inc.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.

Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.

🎯 Themen im Interview mit Etienne Jornod (OM Pharma)

– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments

👉🏽 https://bxplus.ch/bx-musterportfolio/

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’823.22 19.56 S2S3VU
Short 13’094.83 13.71 UEBSLU
Short 13’580.05 8.95 UJOBSU
SMI-Kurs: 12’314.10 29.10.2025 17:31:05
Long 11’736.05 18.56 SHFB5U
Long 11’507.12 13.87 BIYSFU
Long 11’008.02 8.95 BMQS4U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

Kontron 20.58 5.10% Kontron